The price of Opko Health Inc (NASDAQ:OPK) shares last traded on Wall Street rose 3.27% to $1.58.
OPK stock price is now 4.21% away from the 50-day moving average and 16.12% away from the 200-day moving average. The market capitalization of the company currently stands at $1.08B.
With the price target maintained at $2, Barrington Research recently Upgraded its rating from Mkt Perform to Outperform for Opko Health Inc (NASDAQ: OPK). On December 15, 2022, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $3, while ‘Barrington Research’ rates the stock as ‘Mkt Perform’
In other news, FROST PHILLIP MD ET AL, CEO & Chairman bought 199,072 shares of the company’s stock on Nov 29 ’24. The stock was bought for $305,376 at an average price of $1.53. Upon completion of the transaction, the CEO & Chairman now directly owns 211,911,477 shares in the company, valued at $334.82 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 22 ’24, CEO & Chairman FROST PHILLIP MD ET AL bought 100,000 shares of the business’s stock. A total of $159,000 was incurred on buying the stock at an average price of $1.59. This leaves the insider owning 211,712,405 shares of the company worth $334.51 million.
During the past 12 months, Opko Health Inc has had a low of $0.85 and a high of $1.75. As of last week, the company has a debt-to-equity ratio of 0.37, a current ratio of 2.97, and a quick ratio of 2.69. The fifty day moving average price for OPK is $1.5146 and a two-hundred day moving average price translates $1.35795 for the stock.
The latest earnings results from Opko Health Inc (NASDAQ: OPK) was released for 2024-09-30. The net profit margin was -18.80% and return on equity was -9.39% for OPK. The company reported revenue of $173.63 million for the quarter, compared to $178.59 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.78 percent.
